Investors of Alexion Pharmaceuticals (ALXN) have voted in favor of the company’s acquisition by AstraZeneca. Pending regulatory approvals, the transaction is expected to …
One area of the market that has been gaining steam: biotech stocks. A flurry of deals, FDA approvals, and recent innovations in the …
Synageva Biopharma Corp (NASDAQ:GEVA) increased more than 130% to $221.25 in pre-market trading following news that the pharmaceutical company will be acquired by …
In a research note published today, Janney Capital analyst Kimberly Lee maintained a Neutral rating on Alexion Pharmaceuticals (ALXN) with a $162 price …
